Florian Weissinger

Summary

Affiliation: Evangelisches Krankenhaus
Country: Germany

Publications

  1. doi request reprint Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
    Florian Weissinger
    Klinik fur Innere Medizin, Hämatologie Onkologie und Palliativmedizin, Evangelisches Krankenhaus Bielefeld, Schildescher Str 99, 33611 Bielefeld, Germany
    Ann Hematol 91:1161-74. 2012
  2. doi request reprint Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T)
    Florian Weissinger
    Klinik fur Innere Medizin, Hämatologie Onkologie und Palliativmedizin, Evangelisches Krankenhaus Bielefeld, Germany
    Onkologie 34:548-51. 2011

Detail Information

Publications2

  1. doi request reprint Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
    Florian Weissinger
    Klinik fur Innere Medizin, Hämatologie Onkologie und Palliativmedizin, Evangelisches Krankenhaus Bielefeld, Schildescher Str 99, 33611 Bielefeld, Germany
    Ann Hematol 91:1161-74. 2012
    ..In this review we discuss all aspects of infections after autologous stem transplantation, including epidemiology, diagnostics, therapeutic algorithms, prophylaxis and supportive therapy...
  2. doi request reprint Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T)
    Florian Weissinger
    Klinik fur Innere Medizin, Hämatologie Onkologie und Palliativmedizin, Evangelisches Krankenhaus Bielefeld, Germany
    Onkologie 34:548-51. 2011
    ..Second-line combinations are currently evaluated in various studies...